[1] Lionakis, MS. New insights into innate immune control of systemic candidiasis[J]. Med Mycol, 2014,52(6):555-564.
[2] Cheah HL, Lim V,Sandai D. Inhibitors of the glyoxylate cycle enzyme ICL1 in Candida albicans for potential use as antifungal agents[J]. PLoS One, 2014, 9(4):e95951.
[3] Ahn CH, Won TH, Kim H, et al. Inhibition of Candida albicans isocitrate lyase activity by cadiolides and synoilides from the ascidian Synoicum sp[J]. Bioorg Med Chem Lett, 2013, 23(14):4099-4101.
[4] Dobb KS, Kaye SJ, Beckmann N, et al.Characterisation of the Candida albicans phosphopantetheinyl transferase ppt2 as a potential antifungal drug target[J]. PLoS One, 2015, 10(11):e0143770.
[5] Crawford JM,Vagstad AL, Ehrlich KC, et al. Acyl-carrier protein-phosphopantetheinyltransferase partnerships in fungal fatty acid synthases[J]. Chembiochem,2008, 9(10):1559-1563.
[6] Allen G, Bromley M, Kaye SJ, et al. Functional analysis of a mitochondrialphosphopantetheinyl transferase (PPTase) gene pptB in Aspergillus fumigatus[J]. Fungal Genet Biol, 2011, 48(4):456-464.
[7] Foley TL, Rai G, Yasgar A, et al. 4-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)-N-(4-methoxypyridin-2-yl)piperazine-1-carbothioamide(ML267), a potent inhibitor of bacterial phosphopantetheinyl transferase that attenuates secondary metabolism and thwarts bacterial growth[J]. J Med Chem, 2014, 57(3):1063-1078.
[8] 柴燕涛,姜棋予,谢国明,等.包涵体蛋白3种纯化方法的比较[J].中国医药导报,2016,13(10):4-6. |